Emerald Corporate Group

Emerald Corporate Group Emerald Corporate Group Pty Ltd
Strategic Healthcare Consultancy

We specialise in developing health economic and reimbursement strategic plans and implement them both globally and at operating company level, including from in-licensing to Phase IV trial design. Over 20 years pharmaceutical industry experience including clinical research, health economics, reimbursement, pricing and business development working in both operating company level (Australia, Belgium

and USA) and at global level based in the USA. We have conducted strategic planning for global pricing & market access, prospective/retrospective health economic research, primary and secondary pricing research, health economic modeling, project management, proposal/protocol writing, and publication development/management. Emerald Corporate Group has partnerships and alliances that enable it to conduct this research in Asia Pacific, Japan and Europe.

The evening before….31.12.2022   #2023
01/01/2023

The evening before….31.12.2022
#2023

Sign up to    &   Specialisation Course to gain knowledge, connections & skills for building a business & bringing your ...
17/04/2022

Sign up to & Specialisation Course to gain knowledge, connections & skills for building a business & bringing your solution to market. 25-27 May 2022, 9am-5pm. FREE to anyone in buff.ly/3uPuScn

“Sign up to Therapeutics & Pharmaceuticals Specialisation Course to gain knowledge, connections & skills for building a business & bringing your solution to market. 25-27 May 2022, 9am-5pm. https://t.co/m63llI0tZV”

23/03/2022

Australian Government extending the finalisation of the National Medicines Policy ( ) Review until after the Federal election. has heeded calls from Medicines Australia, $patient groups, health bodies, and via Medicines Australia

Government opts for additional consultation on National Medicines Policy (NMP) Review 24 March 2022: The Government has heeded the calls from Medicines Australia, patient groups, health bodies, and industry by extending the finalisation of the National Medicines Policy (NMP) Review until after the F...

Cancer Australia invites us to share our vision for the Australian   Plan.To help frame your thinking you can read the C...
28/12/2021

Cancer Australia invites us to share our vision for the Australian Plan.

To help frame your thinking you can read the Communique & view presentations from a Ministerial Roundtable about the Australian Cancer Plan held in April 2021.

“Calling all organisations & people with an interest in the future of cancer outcomes and cancer care in Australia! Have your say & contribute to the Consultation Hub. Visit https://t.co/gpKxI2bHBk”

Venomous bites and stings in Australia 2017-18 from , https://buff.ly/2O0W5pJ.  Over 3,500 Australians were hospitalised...
04/03/2021

Venomous bites and stings in Australia 2017-18 from , https://buff.ly/2O0W5pJ. Over 3,500 Australians were hospitalised due to contact with a venomous animal or plant in 2017–18. Find out more in the AIHW's new report: https://buff.ly/388HpLX...

Over 3,500 Australians were hospitalised due to contact with a venomous animal or plant in 2017–18. Find out more in the AIHW's new report: https://www.aihw....

Clinical trials at risk due to RDTI cuts, the  CEO  says government’s plan to make a series of changes to the scheme cou...
17/09/2020

Clinical trials at risk due to RDTI cuts, the CEO says government’s plan to make a series of changes to the scheme could significantly damage Australia's competitive advantage via InnovationAus https://buff.ly/3mt733M

Australia risks losing its competitive advantage in clinical trials and seeing companies move operations elsewhere if government goes ahead with its planned changes to the research and development tax incentive, according to ARCS Australia chief executive Shanny Dyer.Australia has a good reputation....

Should   rates be selectively applied in health economic evaluations?
07/09/2020

Should rates be selectively applied in health economic evaluations?

Australia’s National  -19 Clinical Evidence Taskforce, a specialist team bringing together some of  ’s leading health gr...
05/06/2020

Australia’s National -19 Clinical Evidence Taskforce, a specialist team bringing together some of ’s leading health groups, has given its recommendation for routine use ’s .

Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.

 Value & Outcomes Spotlight, the Research Roundup in this month's edition looks at key articles that discuss how healthc...
06/05/2020

Value & Outcomes Spotlight, the Research Roundup in this month's edition looks at key articles that discuss how healthcare decision makers grapple with a variety of evidence, and how they interpret that . buff.ly/3asLh8T

“The Research Roundup in this month's Value & Outcomes Spotlight looks at key articles that discuss how healthcare decision makers grapple with a variety of evidence, and how they interpret that data. https://t.co/O6RHb8yRZ7

Great simple device from  ...the   UV device...pop in your phone for 20 seconds and sanitize your case and screen while ...
04/04/2020

Great simple device from ...the UV device...pop in your phone for 20 seconds and sanitize your case and screen while you clean/sanitise your hands and then head off to meeting.

02/04/2020

Timely $webinar from on The Economics of COVID-19: Exploring key issues of impact on the economy...Sydney, Australia timezone is Thu, 2 Apr 2020 at 11:00 pm AEDT.
https://buff.ly/39CBTPQ

Chair: Winnie Yip, Professor of Global Health Policy and Economics and Director of the Harvard China Health Partnership, Harvard T.H. Chan School of Public Health

 : Excellent resource on   -  download presentation of   First Seminar Series w 's  on how to crack the US 🇺🇸 market! bu...
20/03/2020

: Excellent resource on - download presentation of First Seminar Series w 's on how to crack the US 🇺🇸 market! buff.ly/392jMlX

“ : here's a wrap-up of our First Seminar Series w 's on how to crack the 🇺🇸 market! Follow our SE team of , , & on the sessions in QLD, WA, NSW & meetings in VIC https://t.co/IvsH5plXoS”

Address

43 Victoria Street
McMahons Point, NSW
2060

Alerts

Be the first to know and let us send you an email when Emerald Corporate Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Emerald Corporate Group:

Share